IX Biopharma (SGX:42C) added Brian Kennedy as scientific advisor to its scientific advisory board, according to a Monday filing with the Singapore Exchange.
Kennedy is the director of the Healthy Longevity Translational Research Program at the National University of Singapore.
He will help the healthcare company develop its healthspan supplements through its supplements subsidiary, Entity Health, the filing stated.
Price (SGD): S$18502.69, Change: S$+160, Percent Change: +0.87%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments